LAMOTRIGINE ER 25 MG TABLET

lamotrigine extended release
$0.4168per EA

Strength

25 mg/1

Manufacturer

Endo USA Inc.

NDC

49884056111

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA201791

On Market Since

1/18/2013

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price History

1W

0.0%

1M

+12.3%

3M

+27.3%

6M

+0.5%

1Y

+5.1%

3Y

-29.6%

5Y

-61.7%

All

-90.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.